LLY ▲ +0.2% - Eli Lilly and Company $LLY NVO Lilly, Novo face lawsuits over GLP-1 vision loss risk, WSJ Eli Lilly shares rose 0.2% after a Wall Street Journal report that the company and Novo Nordisk face lawsuits related to potential vision loss risks associated with GLP-1 drugs. The modest gain suggests investors may be discounting the litigation risk, or the market is awaiting more details on the scope and merit of the claims. 19-SEP-2026 11:22 AM ET